Source: Medical Device Network

Suono Bio: Suono Bio doses first patient with SuonoCalm therapeutic platform

The next-generation technology will enable topical and oral delivery of therapeutics to the gastrointestinal tract. The post Suono Bio doses first patient with SuonoCalm therapeutic platform appeared first on Medical Device Network.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Scott Kellogg's photo - CEO of Suono Bio

CEO

Scott Kellogg

CEO Approval Rating

86/100

Read more